Recent Patent and Court Developments in the U.S. and Europe Reinforce Danone’s Patent Position as Global Commercialization of Akkermansia MucT® Expands

The Akkermansia Company, a Danone subsidiary, announced significant legal victories strengthening its intellectual property position for Akkermansia muciniphila-based products. A new U.S. patent covers all forms of substantially purified Akkermansia, the PTAB confirmed priority of invention for metabolic disorder treatments, and a Belgian court recognized the original inventors' rights. The company plans to expand U.S. direct-to-consumer and healthcare practitioner channels while growing presence in Europe and Asia-Pacific.